BCFS002021-NYU Langone-Charvet-180-[Landing Page] -

Remote Depression In MS
Research Study

NYU Langone Health is studying non-drug ways to treat depression in people with multiple sclerosis (MS). This study will test whether at-home noninvasive brain stimulation (tDCS) combined with mindfulness meditation can help reduce depression symptoms in people with MS.

Fast Facts

Diagnosed with multiple sclerosis

Experiencing symptoms of depression

Compensation
up to $150

Conducted
remotely

Additional Information

Why is this study being done?

This study is being conducted to better understand depression in people with multiple sclerosis and to explore ways to improve treatment options using non-medication approaches.

Is this study for me?

You may be eligible for this study if you meet the following criteria.

Inclusion Criteria:

Diagnosed with multiple sclerosis (any subtype)
Experiencing symptoms of depression
Ages 18–65

Exclusion Criteria:

Major or unstable medical or neurological conditions other than MS that would interfere with study participation

What will happen if I participate in the study?

Overall Duration
The study lasts about 5.5 months.

At-Home Activities
If eligible, participants will be mailed all study equipment to use at home. They will complete 30 daily sessions over 6–8 weeks (Monday through Friday), paired with mindfulness meditation. Each session is done under remote supervision. Participants will also complete follow-up check-ins at 1, 2, and 3 months after treatment.

Will I be paid for being in this research study?

Participants may receive up to $150 for their time.

Will it cost me anything to participate in this study?

There is no cost for you to participate in our research study.